Salazar, Ramón http://orcid.org/0000-0001-9419-6232
,
Capdevila, Jaume
Manzano, Jose Luis
Pericay, Carles
Martínez-Villacampa, Mercedes
López, Carlos
Losa, Ferrán
Safont, María José
Gómez-España, Auxiliadora
Alonso-Orduña, Vicente
Escudero, Pilar
Gallego, Javier
García-Paredes, Beatriz
Palacios, Amalia
Biondo, Sebastiano
Grávalos, Cristina
Aranda, Enrique
Funding for this research was provided by:
F. Hoffmann-La Roche (Award was granted to TTD group. It was directed to the collection and analysis of data, documentation, writing the manuscript and bureaucratic aspects with health administrations)
Article History
Received: 8 November 2019
Accepted: 18 November 2020
First Online: 27 November 2020
Ethics approval and consent to participate
: The study was performed following the Declaration of Helsinki and Good Clinical Practice Guidelines, and written informed consent was obtained from all patients before taking part in the study.The protocol was approved by the institutional review boards of all participating centers: Instituto Catalán de Oncología, Hospital 12 de Octubre, Hospital Universitario Reina Sofía, Hospital Universitari Vall D’Hebrón, Hospital U. German Trias I Pujol, Complejo Sanitario Parc Taulí, Hospital U. Marqués de Valdecilla, Hospital G. de L’Hospitalet, Hospital General U. de Valencia, Hospital Universitario Miguel Servet, Hospital Clínico U. Lozano Blesa, Hospital General U. de Elche, Hospital C. U. San Carlos.Reference ethics committee: Comité Ético de Investigación Clínica del Hospital Universitario 12 de Octubre, Avda de Córdoba, s/n, 28,041 Madrid
: This manuscript does not contain any details, images or videos relating to individual persons.
: E.Aranda has received honoraria for advisory role from Amgen, Bayer, Celgene, Merck, Roche, Sanofi. Beatriz García Paredes has received honoraria from Roche. Carlos López has received honoraria from advisory role, research funding and other honoraria from Roche. The other authors have stated they have no conflicts of interest.